World’s First Zika Vaccine Developed by Indian Scientists

For residents of rural Texas, access to medical care can depend on where they live, whether they have health insurance, and how far they must travel to reach a physician.

Have you ever wondered what a dermatologist's top skincare recommendations are

The national recognition underscores the system's commitment to delivering exceptional cardiac care and life-saving outcomes for Rio Grande Valley patients.

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.”